A detailed history of Northern Trust Corp transactions in Ptc Therapeutics, Inc. stock. As of the latest transaction made, Northern Trust Corp holds 675,262 shares of PTCT stock, worth $26.5 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
675,262
Previous 658,459 2.55%
Holding current value
$26.5 Million
Previous $20.1 Million 24.42%
% of portfolio
0.0%
Previous 0.0%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$30.39 - $37.66 $510,643 - $632,800
16,803 Added 2.55%
675,262 $25.1 Million
Q2 2024

Aug 14, 2024

SELL
$24.69 - $40.12 $408,421 - $663,665
-16,542 Reduced 2.45%
658,459 $20.1 Million
Q1 2024

May 14, 2024

SELL
$24.15 - $31.95 $334,380 - $442,379
-13,846 Reduced 2.01%
675,001 $19.6 Million
Q4 2023

Feb 13, 2024

SELL
$18.07 - $29.37 $42,392 - $68,902
-2,346 Reduced 0.34%
688,847 $19 Million
Q3 2023

Nov 13, 2023

BUY
$22.41 - $41.99 $113,417 - $212,511
5,061 Added 0.74%
691,193 $15.5 Million
Q2 2023

Aug 11, 2023

BUY
$40.4 - $59.1 $1.18 Million - $1.73 Million
29,269 Added 4.46%
686,132 $27.9 Million
Q1 2023

May 15, 2023

BUY
$38.16 - $48.86 $196,523 - $251,629
5,150 Added 0.79%
656,863 $31.8 Million
Q4 2022

Feb 13, 2023

BUY
$33.53 - $54.79 $137,540 - $224,748
4,102 Added 0.63%
651,713 $24.9 Million
Q3 2022

Nov 14, 2022

SELL
$41.85 - $53.85 $333,042 - $428,538
-7,958 Reduced 1.21%
647,611 $32.5 Million
Q2 2022

Aug 12, 2022

SELL
$25.6 - $45.23 $428,902 - $757,783
-16,754 Reduced 2.49%
655,569 $26.3 Million
Q1 2022

May 13, 2022

SELL
$33.33 - $44.6 $1.21 Million - $1.62 Million
-36,300 Reduced 5.12%
672,323 $25.1 Million
Q4 2021

Feb 08, 2022

SELL
$35.36 - $41.86 $203,602 - $241,029
-5,758 Reduced 0.81%
708,623 $28.2 Million
Q3 2021

Nov 15, 2021

SELL
$37.01 - $44.74 $781,096 - $944,237
-21,105 Reduced 2.87%
714,381 $26.6 Million
Q2 2021

Aug 13, 2021

BUY
$37.95 - $49.37 $211,305 - $274,892
5,568 Added 0.76%
735,486 $31.1 Million
Q1 2021

May 12, 2021

SELL
$46.8 - $68.92 $2.26 Million - $3.33 Million
-48,389 Reduced 6.22%
729,918 $34.6 Million
Q4 2020

Feb 11, 2021

SELL
$47.96 - $67.64 $1.12 Million - $1.58 Million
-23,290 Reduced 2.91%
778,307 $47.5 Million
Q3 2020

Nov 16, 2020

SELL
$45.41 - $57.07 $1.71 Million - $2.15 Million
-37,747 Reduced 4.5%
801,597 $37.5 Million
Q2 2020

Aug 14, 2020

BUY
$42.56 - $54.98 $2.32 Million - $3 Million
54,583 Added 6.96%
839,344 $42.6 Million
Q1 2020

May 14, 2020

BUY
$32.37 - $59.36 $615,515 - $1.13 Million
19,015 Added 2.48%
784,761 $35 Million
Q4 2019

Feb 14, 2020

BUY
$32.22 - $50.07 $280,958 - $436,610
8,720 Added 1.15%
765,746 $36.8 Million
Q3 2019

Nov 13, 2019

BUY
$33.82 - $48.17 $2.53 Million - $3.6 Million
74,794 Added 10.96%
757,026 $25.6 Million
Q2 2019

Aug 13, 2019

BUY
$35.42 - $45.0 $441,120 - $560,430
12,454 Added 1.86%
682,232 $30.7 Million
Q1 2019

May 13, 2019

BUY
$28.09 - $39.49 $2.23 Million - $3.14 Million
79,551 Added 13.48%
669,778 $25.2 Million
Q4 2018

Feb 12, 2019

SELL
$29.83 - $46.51 $5.13 Million - $8 Million
-172,111 Reduced 22.58%
590,227 $20.3 Million
Q3 2018

Nov 14, 2018

BUY
$33.9 - $47.77 $862,619 - $1.22 Million
25,446 Added 3.45%
762,338 $35.8 Million
Q2 2018

Sep 18, 2018

SELL
$25.7 - $47.88 $70,546 - $131,430
-2,745 Reduced 0.37%
736,892 $24.9 Million
Q2 2018

Aug 14, 2018

BUY
$25.7 - $47.88 $1.91 Million - $3.57 Million
74,501 Added 11.2%
739,637 $24.9 Million
Q1 2018

May 09, 2018

SELL
$17.46 - $32.59 $44,016 - $82,159
-2,521 Reduced 0.38%
665,136 $18 Million
Q4 2017

Feb 14, 2018

SELL
$15.14 - $20.89 $144,935 - $199,979
-9,573 Reduced 1.41%
667,657 $11.1 Million
Q3 2017

Nov 13, 2017

BUY
$16.81 - $21.61 $11.4 Million - $14.6 Million
677,230
677,230 $13.6 Million

Others Institutions Holding PTCT

About PTC THERAPEUTICS, INC.


  • Ticker PTCT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 71,541,000
  • Market Cap $2.81B
  • Description
  • PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders. Its portfolio pipeline includes commercial products and product candidates in various stages of development, including clinical, pre-clinical and research and discovery stages, focuses on...
More about PTCT
Track This Portfolio

Track Northern Trust Corp Portfolio

Follow Northern Trust Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.